Carestream Molecular introduces in vitro imaging system

Carestream Molecular Imaging is introducing its new Gel Logic 6000 PRO, a system for imaging gel, blots and plates using multiple modalities including chemiluminescence, UV and multi-wavelength fluorescence and radioisotopic labels in a single platform.

These modalities can be captured in sequence, according to the Woodbridge, Conn.-based company. The Gel Logic 6000 PRO system comes with new Multiplex Analysis Software, an image capture and analysis program that allows researchers to capture, overlay and analyze data from up to four layers within an image. 

Other features include:
  • A 4.2MP camera with fixed lens (f/0.95), which results in greater sensitivity for chemiluminescence and fluorescent applications.
  • An automated broadband UV trans-illuminator sample platform with 3X zoom for samples (including blots, membranes and plates) up to 18 x 18 cm.
  • LED illumination (including epi-white lights and 5 LED modules) for white light, RGB and NIR imaging mounted to the sample platform.

With the Gel Logic 6000 PRO, researchers can use the same multi-faceted approach for in vitro experiments (such as western blotting, DNA gels, chemi blots, fluorescent blots and more) that they would with microscopy or in vivo experiments.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.